GF
ABMD

Gabelli Funds’s Abiomed Inc ABMD Stock Holding History

Gabelli Funds’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-800
Closed -$250K – 1447
2021
Q2 		$250K Hold
800
– – ﹤0.01% 1195
2021
Q1 		$255K Hold
800
– – ﹤0.01% 1164
2020
Q4 		$259K Sell
800
-1,300
-62% -$360K ﹤0.01% 1099
2020
Q3 		$582K Hold
2,100
– – ﹤0.01% 908
2020
Q2 		$507K Sell
2,100
-1,000
-32% -$201K ﹤0.01% 897
2020
Q1 		$450K Buy
3,100
+1,100
+55% +$183K ﹤0.01% 899
2019
Q4 		$341K Buy
+2,000
New +$371K ﹤0.01% 978

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Gabelli Funds's ABMD Position: Q3 2021 in Review

Gabelli Funds sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 800 shares — an estimated $250K sold.

Gabelli Funds first reported a position in ABMD in Q4 2019 and held it in 7 quarters. The position peaked at $582K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Gabelli Funds reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Gabelli Funds sold 800 Abiomed Inc shares in Q3 2021, an estimated $250K.
  • Gabelli Funds first reported a position in Abiomed Inc in Q4 2019 and held it in 7 quarters.
  • Gabelli Funds's Abiomed Inc position peaked at $582K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Gabelli Funds's 13F filing for Q3 2021, filed 12 Nov 2021.